Summary
The product Drostanolone Enanthate, manufactured by DuncanPharma.eu, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number JF6110, was submitted by the client DuncanPharma.eu and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Drostanolone Enanthate, with a concentration of 195.81 mg/ml, which is slightly below the typical labeled claim of 200 mg/ml by 2.095%.
The testing process was conducted on 24 May 2024. While the results confirm accurate dosing, scrutiny of client-submitted samples is essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: DuncanPharma.eu
- Product Name: Drostanolone Enanthate
- Active Ingredient: Drostanolone Enanthate
- Batch Number: JF6110
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #42617
- Testing Ordered: 15 May 2024
- Sample Received: 23 May 2024
- Analysis Conducted By: Janoshik Analytical
- AProduct Submitted By: Optitropin.EU (Reseller)
- Analysis Paid For By: Optitropin.EU
Testing Results
- Specification: 200 mg/ml (typical label claim)
- Measured Concentration: 195.81 mg/ml
- Accuracy: 97.905% (2.095% below the typical label claim)
- Variance: 2.095
Verification Details
- Verification URL: https://janoshik.com/tests/42617_TVZ533IKMBHI
Evaluation of Client-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission by the client. Clients may select specific batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Drostanolone Enanthate is slightly underdosed, with a measured concentration of 195.81 mg/ml. This result reflects reasonable quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Client-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
